Zurcher Kantonalbank Zurich Cantonalbank Decreases Position in Option Care Health, Inc. (NASDAQ:OPCH)

Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCHFree Report) by 31.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 48,391 shares of the company’s stock after selling 21,728 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Option Care Health were worth $1,123,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in OPCH. Cornerstone Investment Partners LLC lifted its position in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after acquiring an additional 333 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Assetmark Inc. boosted its position in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after buying an additional 487 shares during the last quarter. Pacer Advisors Inc. increased its holdings in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after buying an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management increased its holdings in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after buying an additional 550 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

NASDAQ OPCH opened at $34.52 on Thursday. The business’s fifty day moving average is $31.43 and its 200 day moving average is $28.29. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.85. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.71 billion, a PE ratio of 29.01, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research reports. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $33.00.

Check Out Our Latest Report on Option Care Health

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Stories

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCHFree Report).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.